Sitagliptin differs in chemical structure and pharmacological action from GLP-I analogues, insulin, sulfonylurea derivatives or meglitinides, biguanides, peroxisome proliferator-activated receptor y-receptor agonists (PPARY), alphaglucosidase inhibitors and amylin analogues
Doctors warn against the serious long-term health problems caused by a regular loss of muscle mass in patients who have adopted a yoyo regime of weight loss and regain
Background There were two GLP-1 products that were initially approved and marketed for treating type-2 diabetes but, because they also had successful weight loss results, the manufacturers each got FDA approval to sell the products under two separate indications, one indicated for type 2 diabetes and one for weight loss, each with its own brand name and National Drug Code (NDC) identification number
B12 injections work differently by providing a direct and efficient way to restore your energy levels
The increase in consumer awareness about the importance of antioxidants, coupled with research on the therapeutic applications of SAG, has been a driving force for this market